Abciximab-induced alveolar hemorrhage after percutaneous coronary intervention

Abciximab, a platelet glycoprotein (GP) IIb/IIIa inhibitor, has been shown to improve clinical outcomes in patients undergoing percutaneous coronary intervention. However, there is a well-documented increase in bleeding risk associated with the use of this agent. Spontaneous pulmonary hemorrhage is...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Conley, Maria, Patino, Gilberto, Romick, Benjamin, Almaleh, Michael, Campbell, Charles, Hawkins, Karin, Moore, Scott, Allan, Patrick
Format: Artigo
Idioma:Inglês
Publicat: Pulsus Group Inc 2008
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2644574/
https://ncbi.nlm.nih.gov/pubmed/18273491
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars